Company intelligence / Profile preview

Bio Refine

Ownership: Private
Development stage: Clinical

Overview

Bio Refine has developed an endovascular annuloplasty remodeling system designed for the repair of mitral and tricuspid heart valves without requiring an implant. The current status suggests development is ongoing; no published clinical results are available in public sources.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-implant medical device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Bio Refine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Refine.

Explore the full profile